Insulet Corp (PODD)
252.00
+9.64 +3.98%
NASDAQ
Mar 5, 20:00
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 904.40M |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 0.10 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 6.80M |
Profitability | |
Gross Profit Margin (Quarterly) | 65.46% |
Profit Margin (Quarterly) | -6.95% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 0.00% |
Price and Valuation | |
Market Cap | 16.65B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 18.27 |
PE Ratio | 2520.00 |
Price to Book Value | 27.59 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 1.755 |
Free Cash Flow (Quarterly) | -70.70M |
Return on Equity | Upgrade |
View All PODD News
News
-
WireHeadlineTime (ET)
-
MT Newswires02/25 13:42
-
MT Newswires02/25 10:04
-
Yahoo02/24 16:11
-
Yahoo02/24 14:25
-
MT Newswires02/24 12:04
-
MT Newswires02/24 11:11
-
MT Newswires02/24 09:40
-
Yahoo02/23 22:30
-
Yahoo02/23 16:45
-
SA Breaking News02/23 16:27
-
MT Newswires02/23 16:21
-
MT Newswires02/23 16:03
-
Yahoo02/23 16:01
-
Yahoo02/10 04:44
-
Yahoo02/08 16:01
-
MT Newswires01/29 07:05
-
SA Breaking News01/19 14:50
-
Yahoo01/19 09:56
-
Yahoo01/18 06:00
-
Yahoo01/11 06:00
View All Events
Events
Date | Type | Description |
---|---|---|
05/07/2021 | Earnings | Insulet Corp First Quarter Earnings Results for 2021 |
05/07/2021 | Misc | Insulet Corp First Quarter Earnings Conference Call for 2021 |
02/23/2021 | Earnings | Insulet Corp Fourth Quarter Earnings Result for 2020 |
02/23/2021 16:30 EST | Misc | Insulet Corp Fourth Quarter Earnings Conference Call for 2020 |
11/04/2020 | Earnings | Insulet Corp Third Quarter Earnings Result for 2020 |
11/04/2020 16:30 EST | Misc | Insulet Corp Third Quarter Earnings Conference Call for 2020 |
08/06/2020 16:30 EDT | Misc | Insulet Corp Second Quarter Earnings Conference Call for 2020 |
08/06/2020 | Earnings | Insulet Corp Second Quarter Earnings Result for 2020 |
05/29/2020 10:00 EDT | Misc | Insulet Corp Annual General Meeting for 2019 |
05/07/2020 16:30 EDT | Misc | Insulet Corp First Quarter Earnings Conference Call for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.insulet.com
- Investor Relations URL: http://investor.insulet.com/index.cfm
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Medical Devices
- Equity Style: Mid Cap/Growth
- Next Earnings Release: May. 07, 2021
- Last Earnings Release: Feb. 23, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 252.00 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
FSMEX | Fidelity® Select Medical Tech and Devcs | 3.90% |
EDOC | Global X Telemedicine & Digital Hlth ETF | 3.87% |
FSPHX | Fidelity® Select Health Care | 2.51% |
POGRX | PRIMECAP Odyssey Growth | 2.11% |
POAGX | PRIMECAP Odyssey Aggressive Growth | 1.80% |
ZUH.TO | BMO Eq Wght US HlthCare Hdgd to CAD ETF | 1.52% |
IHI | iShares US Medical Devices ETF | 1.28% |
CSPFX | American Funds SMALLCAP World 529F | 1.24% |
BMEZ | BlackRock Health Sciences Trust II | 1.05% |
FGCKX | Fidelity® Growth Company K | 0.74% |
BBMC | JPMorgan BetaBuilders US Mid Cap Eq ETF | 0.50% |
SCHM | Schwab US Mid-Cap ETF™ | 0.40% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PODD Tweets Stocktwits
Advertisement